Page last updated: 2024-10-23

bencyclane and Hodgkin Disease

bencyclane has been researched along with Hodgkin Disease in 1 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamberg, E1
Bauer, O1
Herrmann, W1
Kroemer, H1
Lippmann, M1
Segmann, H1
Breddin, K1

Other Studies

1 other study available for bencyclane and Hodgkin Disease

ArticleYear
[Primary shape change of platelets in vitro (author's transl)].
    Blut, 1978, Dec-15, Volume: 37, Issue:6

    Topics: Aspirin; Bencyclane; Blood Platelets; Female; Hodgkin Disease; Humans; In Vitro Techniques; Male; Mi

1978